#China #Beijing #healthcare technology #Clinical Decision Support #Tairex AI

Tairex Unveils Its Revolutionary Multi-Agent AI System

On October 21, 2026, Tairex, a pioneering AI healthcare technology company originating from the Institute for AI Industry Research (AIR) at Tsinghua University, unveiled its groundbreaking Multidisciplinary Human-Agent Collaboration (MHAC) Ecosystem specifically designed for hospitals. This innovative system integrates specialized AI agents to facilitate real-time collaboration between these agents and physicians on clinical cases, aimed at enhancing patient care and clinical outcomes.

1. A New Era of Clinical Training and Collaboration

The MHAC ecosystem operates within a simulated environment that simulates millions of lifelike AI patients, enabling AI doctors to carry out tens of thousands of virtual consultations daily. This unique approach results in the formation of 54 advanced AI doctors proficient in over 20 clinical specialties and capable of addressing tens of thousands of diseases. Impressively, these AI doctors have demonstrated over 96% accuracy on the MedQA dataset, proving their clinical efficacy.

In scenarios where a patient’s case crosses various specialties, the system activates the appropriate agents to provide simultaneous input. Unlike traditional siloed approaches, this innovation allows for a unified interface where AI agents share their clinical reasoning and evidence, with any discrepancies flagged for human physicians to review. For instance, an endocrinology agent may recommend a beta-blocker for palpitations, while a respiratory medicine agent could caution that non-selective beta-blockers might worsen asthma symptoms, suggesting a more suitable selective beta-1 blocker instead.

2. Transforming Clinical Workflows with AI Insights

One of the noteworthy features of Tairex's AI system is its capacity to present real-time recommendations from specialized agents within a single clinical interface. This feature enables healthcare professionals to consider insights from various specialties without the need for time-consuming separate meetings. Moreover, this system empowers AI agents to emulate specialists, thereby extending their expertise to multiple departments and increasing accessibility to high-quality medical resources across primary care facilities.

The underlying philosophy of the MHAC model is that AI is not intended to make critical decisions independently but rather to enhance efficiency and support human-led clinical decision-making processes. By doing so, Tairex aims to bridge the gap between advanced medical knowledge and practical application in healthcare settings.

3. Commitment to Data Security and Compliance

Data security is a fundamental aspect of Tairex's design. The company adheres to international data protection regulations such as the EU's General Data Protection Regulation (GDPR) and South Korea's Personal Information Protection Act (PIPA). Additionally, Tairex has achieved Level 3 certification under China’s Multi-Level Protection Scheme (MLPS), ensuring robust controls over the handling and transfer of sensitive patient data.

In essence, the Multidisciplinary Human-Agent Collaboration Ecosystem developed by Tairex aspires to revolutionize how healthcare institutions, particularly at the primary care level, access and utilize medical resources. By fostering a more equitable healthcare environment and harnessing the potential of AI to augment human decision-making, Tairex is on the forefront of transforming clinical practices for better patient outcomes.

This innovative approach heralds a new chapter in healthcare, bringing the power of advanced AI technology to the hands of more healthcare practitioners, ultimately striving for an equitable health landscape accessible to all.